Aion Therapeutic ROA 2024

Aion Therapeutic Aktienanalyse

What does Aion Therapeutic do?

Aion Therapeutic Inc is a Canadian company specializing in the development of medications derived from cannabis and the research of these compounds. The company was founded in 2017 and has been operating on the Toronto Stock Exchange under the ticker symbol AION. The goal of Aion Therapeutic is to advance the development of innovative therapies based on the medical application of cannabinoids. The company focuses on discovering and testing medications that not only have high efficacy but also have a lower risk of side effects. Aion Therapeutic's business model is built on several pillars. This includes research and development of medications based on cannabis compounds such as CBD and THC. The company works closely with experts in the field of science and cannabinoid pharmaceutical production. Another important area is the distribution of cannabis products, such as seeds, oils, extracts, and dried flowers. The company utilizes innovative technologies and processes to improve the quality and effectiveness of these products. In terms of its business activities, Aion Therapeutic can be divided into different areas. One of the most important is the development of medications based on cannabis extract chemotypes that can be used for the prevention and treatment of diseases such as pain, inflammation, chronic conditions, and neurological disorders. The company collaborates closely with leading research institutes and universities worldwide to focus on developing methods that improve the effectiveness and safety of these products. Aion Therapeutic is also active in the manufacturing and marketing of cannabis products. The company offers high-quality cannabinoid extracts from different hemp varieties, specifically tailored to meet the needs of medical users. These products aim to enhance users' well-being and alleviate symptoms of chronic conditions. Another important area of Aion Therapeutic is the application of cannabis-based products in veterinary medicine. The company focuses on developing veterinary medicines specifically designed for pets such as dogs and cats. Similar to the medical application of CBD and THC in humans, the use in veterinary medicine aims to alleviate chronic pain and inflammation or enhance well-being. In summary, Aion Therapeutic is a company specializing in the development of cannabis-based medications and products. With a focus on new technologies and research findings, the company aims to improve the medical application of CBD and THC and establish them as a credible alternative to conventional medications. Aion Therapeutic ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Aion Therapeutic's Return on Assets (ROA)

Aion Therapeutic's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Aion Therapeutic's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Aion Therapeutic's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Aion Therapeutic’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Aion Therapeutic Stock

What is the Return on Assets (ROA) of Aion Therapeutic this year?

The Return on Assets (ROA) of Aion Therapeutic is -1.24 undefined this year.

What was the ROA of Aion Therapeutic compared to the previous year?

The ROA of Aion Therapeutic has increased by -95.14% compared to the previous year.

What consequences do high ROA have for investors of Aion Therapeutic?

A high ROA is advantageous for investors of Aion Therapeutic, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Aion Therapeutic?

A low ROA can be unfavorable for investors of Aion Therapeutic as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Aion Therapeutic affect the company?

An increase in ROA of Aion Therapeutic can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Aion Therapeutic impact the company?

A reduction in the ROA of Aion Therapeutic can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Aion Therapeutic?

Some factors that can influence the ROA of Aion Therapeutic include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Aion Therapeutic important for investors?

The ROA of Aion Therapeutic is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Aion Therapeutic take to improve ROA?

To improve ROA, Aion Therapeutic can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Aion Therapeutic pay?

Over the past 12 months, Aion Therapeutic paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aion Therapeutic is expected to pay a dividend of 0 CAD.

What is the dividend yield of Aion Therapeutic?

The current dividend yield of Aion Therapeutic is .

When does Aion Therapeutic pay dividends?

Aion Therapeutic pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aion Therapeutic?

Aion Therapeutic paid dividends every year for the past 0 years.

What is the dividend of Aion Therapeutic?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aion Therapeutic located?

Aion Therapeutic is assigned to the '-' sector.

Wann musste ich die Aktien von Aion Therapeutic kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aion Therapeutic from 6/27/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Aion Therapeutic pay the last dividend?

The last dividend was paid out on 6/27/2024.

What was the dividend of Aion Therapeutic in the year 2023?

In the year 2023, Aion Therapeutic distributed 0 CAD as dividends.

In which currency does Aion Therapeutic pay out the dividend?

The dividends of Aion Therapeutic are distributed in CAD.